Medical research

A medical worker gives coronavirus vaccine candidate to a volunteer during a trial at a community health center in Bandung, West Java, Indonesia, Friday, Aug. 14, 2020. Indonesia's only vaccine production company has started this week a so-called phase 3 clinical trials to test a potential coronavirus vaccine developed by a Chinese company. (AP Photo/Kusumadirezza)
August 14, 2020 - 5:52 am
JAKARTA, Indonesia (AP) — More people in Indonesia rolled up their sleeves Friday to test a potential coronavirus vaccine developed by a Chinese company. The Indonesian government announced the partnership between state-owned enterprise Bio Farma and the Chinese company Sinovac BioTech in early...
Read More
People wearing face masks to protect against coronavirus, sit on chairs whilst queuing to be screened and tested for COVID-19 in Eldorado Park outside of Johannesburg, South Africa, Monday, Aug. 3, 2020. (AP Photo/Themba Hadebe)
August 13, 2020 - 8:24 am
JOHANNESBURG (AP) — An Africa-wide study of antibodies to the coronavirus has begun, while evidence from a smaller study indicates that many more people have been infected than official numbers show, the Africa Centers for Disease Control and Prevention said Thursday. Experts are eager to know the...
Read More
In this handout photo taken on Thursday, Aug. 6, 2020, and provided by Russian Direct Investment Fund, a new vaccine is on display at the Nikolai Gamaleya National Center of Epidemiology and Microbiology in Moscow, Russia. Russia on Tuesday, Aug. 11 became the first country to approve a coronavirus vaccine for use in tens of thousands of its citizens despite international skepticism about injections that have not completed clinical trials and were studied in only dozens of people for less than two months. (Alexander Zemlianichenko Jr/ Russian Direct Investment Fund via AP)
August 11, 2020 - 3:35 pm
MOSCOW (AP) — Russia on Tuesday became the first country to approve a coronavirus vaccine, a move that was met with international skepticism and unease because the shots have only been studied in dozens of people. President Vladimir Putin announced the Health Ministry's approval and said one of his...
Read More
Mendy McNulty swabs the nose of her son, Andrew, 7, Tuesday, July 28, 2020, in their home in Mount Juliet, Tenn. Six thousand U.S. parents and kids are swabbing their noses twice a week to answer some of the most vexing mysteries about the coronavirus. The answers could help determine the safety of in-class education during the pandemic. (AP Photo/Mark Humphrey)
August 08, 2020 - 12:22 pm
In a comfy suburb just outside Nashville, a young family swabs their noses twice a month in a DIY study seeking answers to some of the most vexing questions about the coronavirus. How many U.S. children and teens are infected? How many kids who are infected show no symptoms? How likely are they to...
Read More
A child grimaces as a health worker takes a nasal swab sample for COVID- 19 testing through rapid antigen methodology, in New Delhi, India , Friday, Aug. 7, 2020. As India hit another grim milestone in the coronavirus pandemic on Friday, crossing 2 million cases and more than 41,000 deaths, community health volunteers went on strike complaining they were ill-equipped to respond to the wave of infection in rural areas. (AP Photo/Manish Swarup)
August 07, 2020 - 8:29 am
NEW DELHI (AP) — As India hit another grim milestone in the coronavirus pandemic on Friday, crossing 2 million confirmed cases and more than 41,000 deaths, community health volunteers went on strike complaining they were ill-equipped to respond to the wave of infection in rural areas. Even as India...
Read More
In this photo made from footage provided by the Russian Defense Ministry on Wednesday, July 15, 2020, medical workers in protective gear prepare to draw blood from volunteers participating in a trial of a coronavirus vaccine at the Budenko Main Military Hospital outside Moscow, Russia. Russia is boasting that it’s about to be the first country to approve a COVID-19 vaccine, but scientists worldwide are sounding the alarm that the headlong rush could backfire. (Russian Defense Ministry Press Service via AP)
August 07, 2020 - 3:02 am
MOSCOW (AP) — Russia boasts that it’s about to become the first country to approve a COVID-19 vaccine, with mass vaccinations planned as early as October using shots that are yet to complete clinical trials -- and scientists worldwide are sounding the alarm that the headlong rush could backfire...
Read More
FILE - In this July 26, 2020, file photo, federal officers launch tear gas at demonstrators during a Black Lives Matter protest at the Mark O. Hatfield U.S. Courthouse in Portland, Ore. The Associated Press found that there is no government oversight of the manufacture and use of tear gas. Instead, the industry is left to regulate itself. (AP Photo/Marcio Jose Sanchez, File)
August 06, 2020 - 11:41 am
SALEM, Ore. (AP) — On June 2, Justin LaFrancois attended a protest against police violence and racism in downtown Charlotte, North Carolina, where he planned to livestream the event for his alternative newspaper’s website. Shortly into the march, police, who reported that water bottles and rocks...
Read More
FILE - In this June 16, 2020, file photo, French President Emmanuel Macron listens to a researcher as he visits an industrial development laboratory at French drugmaker's vaccine unit Sanofi Pasteur plant in Marcy-l'Etoile, near Lyon, central France. As the race for a vaccine against the new coronavirus intensifies, many rich countries are rushing to the front of the line by placing advance orders for the inevitably limited supply to guarantee their citizens are immunized first. (AP Photo/Laurent Cipriani, Pool)
July 31, 2020 - 12:46 pm
LONDON (AP) — Pharma giants GlaxoSmithKline and Sanofi Pasteur have announced they will supply 100 million doses of an experimental COVID-19 vaccine to the United States as governments buy up supplies in hopes of securing a candidate that works. The United States will pay up to $2.1 billion “for...
Read More
Leon McFarlane a research technician handles a blood sample from a volunteer in the laboratory at Imperial College in London, Thursday, July 30, 2020. Imperial College is working on the development of a COVID-19 vaccine. Scientists at Imperial College London say they are immunizing hundreds of people with an experimental coronavirus vaccine in an early trial after seeing no worrying safety problems in those vaccinated so far. Dr. Robin Shattock told the Associated Press that he and colleagues had just finished a very slow and arduous process of testing the vaccine at a low dose in a small number of participants and would now be expanding the trial to about 300 people, including those over 75. (AP Photo/Kirsty Wigglesworth)
July 30, 2020 - 3:49 pm
LONDON (AP) — Scientists at Imperial College London say they are immunizing hundreds of people with an experimental coronavirus vaccine in an early trial after seeing no worrying safety problems in a small number vaccinated so far. Dr. Robin Shattock, a professor at the college, told The Associated...
Read More
In this image from video provided by Washington University, researcher Nicolas Barthelemy works on a p-tau217 test for Alzheimer's disease at a laboratory in St. Louis, Mo., on Monday, July 27, 2020. Several companies and universities have developed versions of these tests, which look for a form of tau protein, one of the substances that can build up and damage the brains of people with Alzheimer’s. (Huy Mach/Washington University, St. Louis via AP)
July 28, 2020 - 1:11 pm
An experimental blood test was highly accurate at distinguishing people with Alzheimer’s disease from those without it in several studies, boosting hopes that there soon may be a simple way to help diagnose this most common form of dementia. Developing such a test has been a long-sought goal, and...
Read More

Pages